Nebivolol

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1309 publications

Retraction Note: Renal protective effect of nebivolol in rat models of acute renal injury: role of sodium glucose co-transporter 2.

Retraction Note: Renal protective effect of nebivolol in rat models of acute renal injury: role of sodium glucose co-transporter 2.

Journal: Pharmacological reports : PR
Published: July 29, 2026

Therapeutic use of cardioselective beta-blockers for patients with chronic obstructive pulmonary disease: a review of current clinical evidence.

Therapeutic use of cardioselective beta-blockers for patients with chronic obstructive pulmonary disease: a review of current clinical evidence.

Journal: Current medical research and opinion
Published: July 08, 2026

Metabolic Disturbances Associated with Beta-Blocker Therapy: New Insights from a Large-Scale Pharmacovigilance Study.

Metabolic Disturbances Associated with Beta-Blocker Therapy: New Insights from a Large-Scale Pharmacovigilance Study.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: June 26, 2026

Efficacy and Safety of the Extemporaneous Combination Nebivolol/Amlodipine in Patients with Hypertension Uncontrolled on Monotherapy: The BOTTICELLI Study.

Efficacy and Safety of the Extemporaneous Combination Nebivolol/Amlodipine in Patients with Hypertension Uncontrolled on Monotherapy: The BOTTICELLI Study.

Journal: High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension
Published: June 17, 2026

Interpreting Coronary Perfusion Endpoints: A Multidimensional Framework for Physiologic and Clinical Integration.

Interpreting Coronary Perfusion Endpoints: A Multidimensional Framework for Physiologic and Clinical Integration.

Journal: Cardiology in review
Published: June 10, 2026

Development of pH-Sensitive β‑Adrenergic Receptor Antagonists.

Development of pH-Sensitive β‑Adrenergic Receptor Antagonists.

Journal: ACS pharmacology & translational science
Published: May 15, 2026

Reply to the letter to the editor: beta-blockers: vasodilator agents (nebivolol orcarvedilol) may add further on patients with obstructive sleep apnea.

Reply to the letter to the editor: beta-blockers: vasodilator agents (nebivolol orcarvedilol) may add further on patients with obstructive sleep apnea.

Journal: Sleep & breathing = Schlaf & Atmung
Published: April 22, 2026

Protective effect of nebivolol on bleomycin-induced lung fibrosis via suppressing TLR4/IL-1β/MMP-2 and TGF-β/HSP47 signaling pathways in rats.

Protective effect of nebivolol on bleomycin-induced lung fibrosis via suppressing TLR4/IL-1β/MMP-2 and TGF-β/HSP47 signaling pathways in rats.

Journal: Immunopharmacology and immunotoxicology
Published: April 10, 2026

Discovery of potential AXL inhibitors using virtual screening, molecular docking, molecular dynamics, molecular mechanics, and in vitro validation.

Discovery of potential AXL inhibitors using virtual screening, molecular docking, molecular dynamics, molecular mechanics, and in vitro validation.

Journal: Scientific reports
Published: April 08, 2026

Beta-blockers: vasodilator agents (nebivolol or carvedilol) may add further on patients with obstructive sleep apnea.

Beta-blockers: vasodilator agents (nebivolol or carvedilol) may add further on patients with obstructive sleep apnea.

Journal: Sleep & breathing = Schlaf & Atmung
Published: March 30, 2026

Mechanistic intersections of empagliflozin and nebivolol in aging-associated redox and inflammatory pathways.

Mechanistic intersections of empagliflozin and nebivolol in aging-associated redox and inflammatory pathways.

Journal: Frontiers in pharmacology
Published: March 29, 2026

Pharmacological effects of nebivolol on endothelial response in a preeclampsia in vitro model.

Pharmacological effects of nebivolol on endothelial response in a preeclampsia in vitro model.

Journal: Life sciences
Published: March 26, 2026
Showing 1-12 of 1,309

Last Updated: 09/26/2026